Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy (PROTECT) a Multicenter International Randomized Phase III Study of Neoadjuvant Proton Versus Photon Chemoradiotherapy in Locally Advanced Esophageal Cancer

NCT05055648 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT05055648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05055648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy (PROTECT) a Multicenter International Randomized Phase III Study of Neoadjuvant Proton Versus Photon Chemoradiotherapy in Locally Advanced Esophageal Cancer
Lead sponsor
University of Aarhus
Phase
Phase 3
Overall status
Recruiting
Start date
May 1, 2022
Completion date
December 1, 2032
Enrollment
396 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, proton therapy, radiotherapy, side effect